Comorbidities and laboratory parameters associated with SARS-CoV-2 infection severity in patients from the southeast of Mexico: a cross-sectional study.

Background. Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is the etiological agent of the coronavirus disease 2019 (COVID-19) pandemic. Among the risk factors associated with the severity of this disease is the presence of several metabolic disorders. For this reason, the aim of this research was to identify the comorbidities and laboratory parameters among COVID-19 patients admitted to the intensive care unit (ICU), comparing the patients who required invasive mechanical ventilation (IMV) with those who did not require IMV, in order to determine the clinical characteristics associated with the COVID-19 severity. Methods. We carried out a cross-sectional study among 152 patients who were admitted to the ICU from April 1 st to July 31 st, 2021, in whom the comorbidities and laboratory parameters associated with the SARS-CoV-2 infection severity were identified. The data of these patients was grouped into two main groups: "patients who required IMV" and "patients who did not require IMV". The nonparametric Mann-Whitney U test for continuous data and the χ2 test for categorical data were used to compare the variables between both groups. Results. Of the 152 COVID-19 patients who were admitted to the ICU, 66 required IMV and 86 did not require IMV. Regarding the comorbidities found in these patients, a higher prevalence of type 2 diabetes mellitus (T2DM), hypertension and obesity was observed among patients who required IMV vs. those who did not require IMV ( p<0.05). Concerning laboratory parameters, only glucose, Interleukin 6 (IL-6), lactate dehydrogenase (LDH) and C-reactive protein (CRP) were significantly higher among patients who required IMV than in those who did not require IMV ( p<0.05). Conclusion. This study performed in a Mexican population indicates that comorbidities such as: T2DM, hypertension and obesity, as well as elevated levels of glucose, IL-6, LDH and CRP are associated with the COVID-19 severity.

Niveles de procalcitonina y ferritina predicen la gravedad de Covid-19 en pacientes ingresados a la unidad de cuidados intensivos.

No disponible.

Arg913Gln variation of SLC12A3 gene is associated with diabetic nephropathy in type 2 diabetes and Gitelman syndrome: a systematic review.

BACKGROUND: Diabetic nephropathy is a global common cause of chronic kidney disease and end-stage renal disease. A lot of research has been conducted in biomedical sciences, which has enhanced understanding of the pathophysiology of diabetic nephropathy and has expanded the potential available therapies. An increasing number of evidence suggests that genetic alterations play a major role in development and progression of diabetic nephropathy. This systematic review was focused on searching an association between Arg913Gln variation in SLC12A3 gene with diabetic nephropathy in individuals with Type 2 Diabetes and Gitelman Syndrome. METHODS: An extensive systematic review of the literature was completed using PubMed, EBSCO and Cochrane Library, from their inception to January 2018. The PRISMA guidelines were followed and the search strategy ensured that all possible studies were identified to compile the review. Inclusion criteria for this review were: 1) Studies that analyzed the SLC12A3 gene in individuals with Type 2 Diabetes and Gitelman Syndrome. 2) Use of at least one analysis investigating the association between the Arg913Gln variation of SLC12A3 gene with diabetic nephropathy. 3) Use of a case-control or follow-up design. 4) Investigation of type 2 diabetes mellitus in individuals with Gitelman's syndrome, with a history of diabetic nephropathy. RESULTS: The included studies comprised 2106 individuals with diabetic nephropathy. This review shows a significant genetic association in most studies in the Arg913Gln variation of SLC12A3 gene with the diabetic nephropathy, pointing out that the mutations of this gene could be a key predictor of end-stage renal disease. CONCLUSIONS: The results showed in this systematic review contribute to better understanding of the association between the Arg913Gln variation of SLC12A3 gene with the pathogenesis of diabetic nephropathy in individuals with T2DM and GS.

NT2 derived neuronal and astrocytic network signalling.

A major focus of stem cell research is the generation of neurons that may then be implanted to treat neurodegenerative diseases. However, a picture is emerging where astrocytes are partners to neurons in sustaining and modulating brain function. We therefore investigated the functional properties of NT2 derived astrocytes and neurons using electrophysiological and calcium imaging approaches. NT2 neurons (NT2Ns) expressed sodium dependent action potentials, as well as responses to depolarisation and the neurotransmitter glutamate. NT2Ns exhibited spontaneous and coordinated calcium elevations in clusters and in extended processes, indicating local and long distance signalling. Tetrodotoxin sensitive network activity could also be evoked by electrical stimulation. Similarly, NT2 astrocytes (NT2As) exhibited morphology and functional properties consistent with this glial cell type. NT2As responded to neuronal activity and to exogenously applied neurotransmitters with calcium elevations, and in contrast to neurons, also exhibited spontaneous rhythmic calcium oscillations. NT2As also generated propagating calcium waves that were gap junction and purinergic signalling dependent. Our results show that NT2 derived astrocytes exhibit appropriate functionality and that NT2N networks interact with NT2A networks in co-culture. These findings underline the utility of such cultures to investigate human brain cell type signalling under controlled conditions. Furthermore, since stem cell derived neuron function and survival is of great importance therapeutically, our findings suggest that the presence of complementary astrocytes may be valuable in supporting stem cell derived neuronal networks. Indeed, this also supports the intriguing possibility of selective therapeutic replacement of astrocytes in diseases where these cells are either lost or lose functionality.

Non-neuronal, slow GABA signalling in the ventrobasal thalamus targets δ-subunit-containing GABA(A) receptors.

The rodent ventrobasal (VB) thalamus contains a relatively uniform population of thalamocortical (TC) neurons that receive glutamatergic input from the vibrissae and the somatosensory cortex, and inhibitory input from the nucleus reticularis thalami (nRT). In this study we describe γ-aminobutyric acid (GABA)(A) receptor-dependent slow outward currents (SOCs) in TC neurons that are distinct from fast inhibitory postsynaptic currents (IPSCs) and tonic currents. SOCs occurred spontaneously or could be evoked by hypo-osmotic stimulus, and were not blocked by tetrodotoxin, removal of extracellular Ca(2+) or bafilomycin A1, indicating a non-synaptic, non-vesicular GABA origin. SOCs were more common in TC neurons of the VB compared with the dorsal lateral geniculate nucleus, and were rarely observed in nRT neurons, whilst SOC frequency in the VB increased with age. Application of THIP, a selective agonist at δ-subunit-containing GABA(A) receptors, occluded SOCs, whereas the benzodiazepine site inverse agonist ß-CCB had no effect, but did inhibit spontaneous and evoked IPSCs. In addition, the occurrence of SOCs was reduced in mice lacking the δ-subunit, and their kinetics were also altered. The anti-epileptic drug vigabatrin increased SOC frequency in a time-dependent manner, but this effect was not due to reversal of GABA transporters. Together, these data indicate that SOCs in TC neurons arise from astrocytic GABA release, and are mediated by δ-subunit-containing GABA(A) receptors. Furthermore, these findings suggest that the therapeutic action of vigabatrin may occur through the augmentation of this astrocyte-neuron interaction, and highlight the importance of glial cells in CNS (patho) physiology.

Do parents know about the adverse effects of passive smoking and the relationship with respiratory illness on their children?

UNLABELLED: Recent studies still show parental smoke as the number one environmental exposure agent causing asthma in pediatric population. OBJECTIVE: The purpose of this study is to determine the knowledge of parents about the adverse effects of passive smoking and the prevalence of passive smoking in children. DESIGN: Cross sectional study, participants were caregivers of students from first to sixth grade (three private and two public schools) who answered a self-administered survey. Data was analyzed using SPSS. RESULTS: Surveys were collected by availability. Total of caregivers was 594, (47% from private and 53% from public school). The total of estimated children in the survey was 1318, and 48.3% in general had recurrent respiratory illness. Among caregivers, 12.1% (72) reported to be smokers. There were 127 participants who revealed at least 1-3 smokers in their home; these smokers are affecting 167 children who are exposed to secondhand smoke. Among smokers, 16.9% smoked inside the house, 15.5% in their cars and 12.3% smoked in the presence of their children. Participants with higher education had a higher average score on knowledge about adverse effects of smoking (p<.001). Over half of the participants (52%) reported seen anti-smoking promotion on T.V. during previous days. Non-smokers revealed they have seen such promotion recently (p=0.00), but 31% of all participants reported not seen any anti-smoking promotion at all. CONCLUSIONS: The prevalence of smokers in our study was 12.1%. We estimated there was more than one smoker in those households where smoking was allowed. There was a higher prevalence of smokers among parents from public schools. There was no significant difference between passive smoker households and non-smoker households for respiratory illness in their children. Pediatricians are giving information to caregivers about active and passive smoking but still, 34% of smokers reported not receiving any information. We need to reinforce the counseling given to caregivers about the adverse effects of smoking has on environmental pollution, and as a cause of other cancers besides lung cancer, recurrent infections and SIDS.

Development of Ca2+-channel and BK-channel expression in embryos and larvae of Xenopus laevis.

The patterns and density of channels expressed in neurons critically determine their electrical properties. We have examined developmental regulation of Ca2+-channel expression during the maturation of the spinal motor circuits in Xenopus as it develops from an embryo to a larva. In embryonic neurons approximately 60% of the current is carried by N-type channels, 8% by l-type channels and the remainder by an unidentified channel. As the embryo matures, omega-agatoxin-sensitive P/Q channels are gradually expressed and replace the unidentified HVA channel such that at stage 42 approximately 25% of the current is carried by P/Q channels. We have used fluorescent labelling of selective channel toxins to directly observe the distribution of P/Q, N and BK channels. The P/Q channel distribution was most prevalent on the cell surface proximal to the areas of the soma where processes emerge. Both N and BK channels were distributed throughout the soma but still exhibited concentration around the areas adjacent to the emergence of processes from the soma. The patterns of fluorescence labelling during development mirrored the development of the respective ionic currents. Both N and P/Q channels contribute roughly equally to activation of the BK current, suggesting that overlap in the distribution of the N, P/Q and BK channels is important in their functional interdependence. The newly expressed P/Q channels play a role in spike initiation and repetitive firing in larval spinal neurons and contribute to burst generation during swimming in the larva.